Bülent Yalçın

7PUBLICATIONS
30CO-AUTHORS
Cancer geneticsCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersNutritional epidemiology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Sep 25, 2026
Clinical impact of ENIGMA-based variant reclassification on genotype-phenotype analyses in BRCA1- and BRCA2-associated hereditary breast and ovarian cancer.

|Jul 21, 2025
Comparative efficacy of adjuvant FOLFOX vs. FLOT following neoadjuvant FLOT in patients with locally advanced gastric cancer.

Furkan Ceylan, Didem Şener Dede, Safa Can Efil

|Feb 13, 2025
Palliative Radiotherapy in Metastatic Breast Cancer Patients on CDK4/6 Inhibitors: Safety Analysis.

Furkan Ceylan, Mirmehdi Mehdiyev, Burak Bilgin

|Jan 11, 2025
Large Unstained Cells (LUC): A Novel Predictor of CDK4/6 Inhibitor Outcomes in HR+ HER2-Negative Metastatic Breast Cancer.

Furkan Ceylan, Mirmehdi Mehdiyev, Didem Şener Dede

|Jul 25, 2023
The diurnal change of thyroid-stimulating hormone and the effect of this change on thyroid functions in patients with chronic kidney disease.

Hüseyin Soylu, Reyhan Ersoy, Pelin Bal Keske

|Mar 14, 2019
The results of nasopharyngeal cancer patients treated by simultaneous integrated boost technique and concomitant chemotherapy

Mehmet Faik Çetindağ, Atiye Yılmaz Özsavran, Bülent Yalçın

Pageof 2

Frequent Collaborators

3 joint publications

Furkan Ceylan

3 joint publications

Ateş Kutay Tenekeci

3 joint publications

Muhammed Bülent Akıncı

3 joint publications

Mehmet Ali Nahit Şendur